IRWD
Ironwood Pharmaceuticals Inc
NASDAQ: IRWD · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$3.61
+2.85% today
Updated 2026-10-28
Market cap
$571.73M
P/E ratio
4.49
P/S ratio
1.47x
EPS (TTM)
$0.77
Dividend yield
—
52W range
$1 – $6
Volume
1.8M
Ironwood Pharmaceuticals Inc (IRWD) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$3.61
12-Month target
$3.94
2030 Target
$2.48
Intrinsic (DCF)
$33.49
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2027 (E) | 2028 (E) | 2029 (E) | 2030 (E) |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.4B | $0.4B | $0.4B | $0.4B | $0.3B | $0.3B | $0.3B | $0.3B | $0.2B |
| EPS | — | — | — | — | — | — | — | — | — |
CAGR applied: -5.33% (capped 20%) · P/E: 4.49x (capped 25x) · Margin: 33.40%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.